1 / 29

Premarket Processes & Pathways to Market Pre-amendment, Exempt, 510(k), and 513(g)

Premarket Processes & Pathways to Market Pre-amendment, Exempt, 510(k), and 513(g). Chris Kilander – Cook Pharmica, LLC 15 May 2014. Medical Device Risk Classes. Medical Device Risk Classes. General Controls (all classes): Establishment Registration & Device Listing (21 CFR 807, Subpart B)

goldy
Download Presentation

Premarket Processes & Pathways to Market Pre-amendment, Exempt, 510(k), and 513(g)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Premarket Processes & Pathways to MarketPre-amendment, Exempt, 510(k), and 513(g) Chris Kilander – Cook Pharmica, LLC 15 May 2014

  2. Medical Device Risk Classes

  3. Medical Device Risk Classes • General Controls (all classes): • Establishment Registration & Device Listing (21 CFR 807, Subpart B) • Quality System Regulation (21 CFR 820) • Most Class I devices exempt from Design Control (21 CFR 820.30) • PostmarketMedical Device Reporting (21 CFR 803) • Premarket Notification (21 CFR 807 , Subpart E) • Most Class I devices exempt from premarket notification • Labeling (21 CFR 801) • Special Controls (Class II & III): • Product-specific FDA guidance documents and/or recognized standards • Premarket clinical studies • Postmarket clinical studies/registries

  4. Classification Framework • Classification based upon Intended Use • Purpose for which the device is to be used • Objective intent of the persons marketing the device • vs. Indications for Use • By default, medical devices are Class III, however: • FDA may issue classification regulations • Regulations indicate class and exempt or premarket notification status, if appropriate • Regulations establish special controls, when appropriate • ~1,700 device types covering 16 different medical specialties

  5. Classification Framework • 21 CFR 860 – Medical Device Classification Procedures • 21 CFR 862 – Clinical Chemistry & Clinical Toxicology • 21 CFR 864 – Hematology & Pathology • 21 CFR 866 – Immunology & Microbiology • 21 CFR 868 – Anesthesiology • 21 CFR 870 – Cardiology • 21 CFR 872 – Dental • 21 CFR 874 – Ear, Nose & Throat • 21 CFR 876 – Gastroenterology-urology

  6. Classification Framework • 21 CFR 878 – General & Plastic surgery • 21 CFR 880 – General Hospital & Personal Use • 21 CFR 882 – Neurological • 21 CFR 884 – Obstetrical & Gynecological • 21 CFR 886 – Ophthalmic • 21 CFR 888 – Orthopedic • 21 CFR 890 – Physical Medicine • 21 CFR 892 – Radiology

  7. Classification Framework

  8. Classification Framework • FDA Product Codes • No established legislative or regulatory authority • Define specific device types within a classification regulation

  9. Exempt from Premarket Notification • Most Class I devices and some Class II devices are exempt from premarket notification requirements (i.e., 510(k)) • As established by classification regulations • “.9 exceptions” • Each classification regulation includes a general requirement that a device is exempt from premarket notification regulations only if there is already a similar device on the market with the same intended use and fundamental scientific technology • Limitations of exemptions from section 510(k) of the Federal Food, Drug, and Cosmetic Act • If not, manufacturer must still submit a 510(k) for the device

  10. Request for Classification – 513(g) • If there is uncertainty regarding the classification of a medical device, manufacturers can submit a Request for Classification under 513(g) • Subject to user fees ($3,490 for FY2014) • Contents: • Cover letter • Description of the device • Description of what device is to be used for • Proposed labeling (yours and similar, legally marketed device) • Guidance: FDA and Industry Procedures for Section 513(g) Requests for Information under the Federal Food, Drug, and Cosmetic Act (2012)

  11. Premarket Notification – 510(k) • Comparison to predicate device to determine if they are substantially equivalent • 510(k) is “cleared” rather “approved” • Substantial equivalence: • Same intended use as predicate device • Either same technological characteristics as predicate or different technological characteristics but not raise new questions of safety or effectiveness • Predicate device: • Legally marketed Class I or Class II device • Class III device for which FDA has not yet required premarket approval (PMA)

  12. Premarket Notification – 510(k) • If FDA determines not substantially equivalent (NSE): • Resubmit 510(k) with new data • Request Class I or Class II designation via de novo pathway • File reclassification petition • Submit a premarket approval (PMA) application

  13. Identification of a Predicate Device • Product Lifecycle database: • Cleared 510(k)s (or PMAs) • Adverse events • Recalls

  14. Identification of a Predicate Device • Published 510(k) summaries

  15. Identification of a Predicate Device • Competitor marketing materials

  16. Types of 510(k)s • FDA Guidance: The New 510(k) Paradigm: Alternate Approaches to Demonstrating Substantial Equivalence in Premarket Notifications (1998) • Types of 510(k)s not defined within law or regulation

  17. Contents of a Traditional 510(k) • Cover letter & 510(k) cover sheet (Form FDA 3514) • Device name, classification & description • Applicant’s identification & FDA registration number • Substantial equivalence comparison with predicate device(s) • Standards (see Form FDA 3654) • Performance data to demonstrate as safe and effective as predicate • Labeling • Class III Certification & Summary, if applicable • 510(k) summary or statement • Truthful and Accuracy Statement

  18. Contents of a Traditional 510(k) • If applicable: • Software validation • Biocompatibility data • Sterilization and packaging data

  19. Substantial Equivalence Comparison

  20. Special 510(k)s • Modification to manufacturer’s own device • Not applicable for: • Changes to intended use or indications for use • Change to fundamental scientific technology • FDA can and does convert to traditional • Focuses on the changes to your device • Risk management & design control

  21. Special 510(k)s • Contents: • 510(k) coversheet (Form FDA 3514) • Name & 510(k) number for legally cleared device • Description of modified device • Proposed labeling • Concise summary of design control activities • Risk analysis • Verification & Validation activities • Declaration of Conformity with Design Control requirements

  22. Abbreviated 510(k)s • Focus on conformance to an established Special Control • Product-specific FDA guidance document • FDA-recognized product standard • Contents: • 510(k) coversheet (Form FDA 3514) • Description of device • Proposed labeling • Summary report that shows how standard/guidance applied • Specifically how risks were addressed • Justification for deviations from the standard • Declaration of conformity to the standard

  23. Refuse to Accept Process • FDA Guidance: Refuse to Accept Policy for 510(k)s Guidance for Industry and Food and Drug Administration Staff (2012) • Within 15 calendar days, FDA will preview submission for inclusion of appropriate content • Combination device? • Submitted to appropriate Center? • 510(k) eligible? • Organization? • Include appropriate elements?

  24. Standards

  25. Pre-amendment Devices • On the market prior to May 28, 1976 • Documentable evidence • Catalogs/datasheets • Shipping records/invoices • Employee affidavit • Pre-amendment Determination Request – guidance on FDA website

  26. Current Developments in 510(k) • Draft Guidance: The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications [510(k)] (2011) • Modifications to 510(k) devices: • Report to Congress: Report on FDA’s Policy to be Proposed Regarding Premarket Notification Requirements for Modifications to Legally Marketed Devices (January 2014)

  27. 510(k) Tips • More than just gathering engineering and marketing information • Tell the “story” • Work with engineering and marketing • How do you want to market the device? • Clearly state intended use and indications • Address differences between your device and predicate • Implement thorough QC process • RTA checklist

  28. Additional Resources • Guidance for Industry: General/Specific Intended Use, 1998 • K97-1: Deciding When to Submit a 510(k) for a Change to an Existing Device, 1997 • K95-1: 510(k) Requirements During Firm-Initiated Recalls, 1995

  29. Exercise • For the pedicle bone screw, what is the classification? • Classification • Regulation • Product Code • Identify two applicable predicates • Identify applicable standards

More Related